Q2 STOCKS TO BUY

The Silver Lining in the Toll Brothers Stock Pullback

Plus, shares of RVNC and COLL are rallying

Dec 5, 2017 at 2:33 PM
facebook X logo linkedin


U.S. stocks are slightly higher this afternoon. Among the names making big moves are homebuilder Toll Brothers Inc (NYSE:TOL), biotech Revance Therapeutics Inc (NASDAQ:RVNC), and pharma stock Collegium Pharmaceutical Inc (NASDAQ:COLL). Here's a quick look at what's moving shares of TOL, RVNC, and COLL.

TOL Stock Pulls Back to 40-Day After Earnings

Toll Brothers stock is falling today after the company's disappointing earnings report, last seen 7.3% lower at $46.96. This comes after the shares just yesterday touched a 12-year high of $51.08. In fact, they still sport a year-to-date lead of 50.5%, and earlier found support at the 40-day moving average.

However, it would seem short-term options traders were prepared for a pullback. This is according to TOL's Schaeffer's put/call open interest ratio (SOIR) of 1.31, which not only shows put open interest outweighs call open interest among contracts expiring within the next three months, but it ranks in the 88th annual percentile.

RVNC Stock Lives Up to High Analyst Expectations

Revance Therapeutics stock is booming today today, thanks to news its injection for Glabellar lines, or "frown lines," met its goals in two late-stage studies. The shares earlier hit an annual high of $36.50, last seen up 39.6% at $36.30. The equity had been chopping higher over the past year, and today's surge has it breaking free from previous congestion in the $28-$29 region.

However, this rally has failed to produce any bullish analyst attention, but that may be because this group was already extremely upbeat toward RVNC shares. Specifically, all seven covering brokerage firms have "strong buy" recommendations, and the average 12-month price target is $44.38.

COLL Stock Rises Alongside Depomed

Collegium Pharmaceutical has obtained the sales rights to Depomed's (DEPO) pain drugs, Nucynta IR and Nucynta ER, and the stock has rallied 4.5% as a result to trade at $17.70, earlier touching an annual high of $20.92. The shares have roughly doubled since their Oct. 31 low near $9, crushing short sellers in the process. For example, short interest represents 30% of COLL stock's float, which would take almost a week to buy back, going by average daily volumes. However, short interest fell sharply after hitting an all-time high July, and if this trend continues, it could result in tailwinds for Collegium.

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter